Company / Free Cash Flow
Chemed Corp. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$325.5M
FY2025
5-year range
$249.9M / $368.0M
FY2021-FY2025
Trend
-11.5%
vs FY2024
Sector context
#52 of 145
Health Care
What the data says
At $325M, Chemed Corp.'s free cash flow ranks #52 of 145 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from $96M in FY2016 to $430M in FY2020.
Based on SEC 10-K filings.
$325M in FY2025 with a 5-year CAGR of -5.4%.
Improved from $273M to $325M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- -5.4%
- 10-Year CAGR
- -
Sector benchmark
#52 of 145 in Health CareTop 36% of 145This company $325.5M Sector average $770.9M
▼
-57.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.4%, indicating a declining trend.
- In FY2025, free cash flow decreased 11.5% year-over-year.
- Ranks #52 out of 145 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $325.5M | -11.5% |
| FY2024 | $368.0M | +34.6% |
| FY2023 | $273.4M | +8.3% |
| FY2022 | $252.6M | +1.1% |
| FY2021 | $249.9M | -41.9% |
| FY2020 | $430.5M | +73.4% |
| FY2019 | $248.2M | +6.0% |
| FY2018 | $234.3M | +138.6% |
| FY2017 | $98.2M | +2.7% |
| FY2016 | $95.6M | -24.9% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026